Loading...
Changes in Alternative Splicing as Pharmacodynamic Markers for Sudemycin D6
OBJECTIVE: The aim of the study was to define pharmacodynamic markers for sudemycin D6, an experimental cancer drug that changes alternative splicing in human blood. METHODS: Blood samples from 12 donors were incubated with sudemycin D6 for up to 24 hours, and at several time points total RNA from l...
Na minha lista:
| Udgivet i: | Biomark Insights |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5598794/ https://ncbi.nlm.nih.gov/pubmed/28932105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1177271917730557 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|